CoChat
Sign Up
Cited by 139

Shared decision making in mental health: prospects for personalized medicine

Drake, Robert E., Cimpean, Delia, Torrey, William C.·2009·Dialogues in Clinical Neuroscience
DOI 10.31887/dcns.2009.11.4/redrakePMC PMC3181931
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31887/dcns.2009.11.4/redrake

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Empirical evidence contributing to individualized treatment regimens based on tailoring variables, treatment history, and current response status will have the added advantage of supporting shared decision-making by the child and parents with an empirically-informed clinician.

    “Empirical evidence contributing to individualized treatment regimens based on tailoring variables, treatment history, and current response status will have the added advantage of supporting shared decision-making by the child and parents with an empirically-informed clinician [65, 66]”

    From A Sequential Multiple Assignment Randomized Trial (SMART) study of medication and CBT sequencing in the treatment of pediatric anxiety disorders (2021) · cites this paper as [65]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 88

  1. [1]Barry MJ. Fowler FJ Jr. Mulley AG Jr. Henderson JV Jr. Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995 33 771 782 7543639
  2. [2]Wennberg JE. O'Connor AM. Collins ED. Weinstein JN. Extending the P4P agenda, part 1: How Medicare can improve patient decision making and reduce unnecessary care. Health Aff (Millwood). 2007 26 1564 1574 17978377 PMC2213717
  3. [3]Charles C. Gafni A. Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999 49 651 661 10452420
  4. [4]Joosten EA. DeFuentes-Merillas L. de Weert GH. Sensky T. van der Staak CP. de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008 77 219 226 18418028
  5. [5]Edwards A. Elwyn G. Shared Decision-Making in Health Care: Achieving Evidence-Based Patient Choice. New York, NY: Oxford University Press; 2009
  6. [6]Elwyn G. O'Connor A. Stacey D. et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006 333 333 417 PMC1553508 16908462
  7. [7]O'Connor AM. Bennett C. Stacey D. et al. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making. 2007 27 554 574 17873255
  8. [8]Institute of Medicine (U.S). Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders, improving the quality of health care for mental and substance-use conditions. Washington, DC: National Academy Press; 2006
  9. [10]Montori VM. Gafni A. Charles C. A shared treatment decision-making 2 approach between patients with chronic conditions and their clinicians: the F case of diabetes. Health Expect. 2006 9 25 36 16436159 PMC5060323
  10. [11]Wagner EH. Glasgow RE. Davis C. et al. Quality improvement in chronic s illness care: a collaborative approach. St Comm J Qual Improv. 2001 27 63 80 11221012
  11. [12]Mueser KT. Corrigan PW. Hilton DW. et al. Illness management and recovery: a review of the research Psychiatr Serv. 2002 53 1272 1284 12364675
  12. [13]Charles C. DeMaio S. Lay participation in health care decision making: r a conceptual framework. J Health Polit Policy Law. 1993 18 881 904 8120350
  13. [15]Deegan PE. Drake RE. Shared decision making and medication man- 2 agement in the recovery process. Psychiatr Serv. 2006 57 1636 1639 17085613
  14. [16]Schneider C. The Practice of Autonomy: Patients, Doctors, and Medical e Decisions. New York, NY: Oxford University Press; 1998
  15. [17]King JS. Moulton BW. Rethinking informed consent: the case for c shared medical decision-making. Am J Law Med. 2006 32 429 501 17240730
  16. [18]Adams JR. Drake RE. Wolford GL. Shared decision-making preferences I of people with severe mental illness. Psychiatr Serv. 2007 58 1219 1221 17766569
  17. [19]Hamann J. Cohen R. Leucht S. Busch R. Kissling W. Do patients with 2 schizophrenia wish to be involved in decisions about their medical treat- r ment? Am J Psychiatry. 2005 162 2382 2384 16330606
  18. [21]O'Neal EL. Adams JR. McHugo GJ. Van Citters AD. Drake RE. Bartels SJ. Preferences of older, middle-aged and younger adults with severe mental illness for involvement in shared decision making in medical and psychiatric c settings. Am J Geriatr Psychiatry. 2008 16 826 833 18827229
  19. [22]Mistier LA. Drake RE. Shared decision making in antipsychotic manJ agement. J Psychiatr Pract. 2008 14 333 344 19057236
  20. [23]Deegan PE. The lived experience of using psychiatric medication in the: recovery process and a shared decision-making program to support it Psychiatr RehabilJ. 2007 31 62 69 17694717
  21. [24]Hamann J. Mendel R. Cohen R. et al. Self-reported use of shared decision making among psychiatrists in the treatment of schizophrenia. Influence of patient characteristics and decision topics. Psychiatr Serv. 2009 60 1107 1112 19648199
  22. [25]Seale C. Chaplin R. Lelliott P. Quirk A. Sharing decisions in consultations involving anti-psychotic medication: a qualitative study of psychiatrists experiences. Soc Sci Med. 2006 62 2861 2873 16343722
  23. [26]Carpenter W. Gold JM. Lahti AC. et al. Decisional capacity for informed r consent in schizophrenia research. Arch Gen Psychiatry. 2000 57 533 538 10839330
  24. [27]Grisso T. Applebaum PS. The MacArthur treatment competence study. III. Abilities of patients to consent to psychiatric and medical treatments Law Human Behavior. 1995 19 149 174 11660292
  25. [28]Stroup S. Appelbaum P. Swartz MS. et al. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial SchizophrP.es. 2005 80 1 8 16182516
  26. [29]McGurk SR. Mueser KT. Strategies for coping with cognitive impairments of clients in supported employment. Psychiatr Serv. 2006 57 1421 1429 17035559
  27. [30]Swanson J. Swartz M. Ferron J. Elbogen E. Van Dorn R. Psychiatric advance directives among public mental health consumers in five U.S. cities: prevalence, demand, and correlates. J Am Acad Psychiatry Law. 2006 34 43 57 16585234
  28. [31]Bond GR. Salyers MP. Rollins AL. Rapp CA. Zipple AM. How evidencebased practices contribute to community integration. Community Ment Health J. 2004 40 569 588 15672695
  29. [32]Corrigan PW. Recovery from schizophrenia and the role of evidencebased psychosocial interventions. Expert Rev Neurother. 2006 6 993 1004 16831114
  30. [33]Becker DR. Xie H. McHugo GJ. Halliday J. Martinez RA. What predicts supported employment program outcomes? Community Ment Health J. 2006 42 303 313 16532378
  31. [34]Bond GR. Supported employment: evidence for an evidence-based practice. Psychiatr Rehabil J. 2004 27 345 359 15222147
  32. [35]Mueser KT. Glynn SM. Liberman RP. Behavioral family management for serious psychiatric illness. New Dir Ment Health Serv. 1994 37 50 7935286
  33. [36]Mueser KT. Drake R.E.. Treatment of co-occurring substance use disorders using shared decision making and electronic decision support systems. In: Rudnick A, Roe D, eds. Serious Mental Illness (SMI): Person-centered Approaches. Radcliff Press. In press
  34. [37]Miller AL. Crismon Ml. Rush AJ. et al. The Texas Medication Algorithm Project: Clinical results for schizophrenia. Schizophr Bull. 2004 30 627 647 15631256
  35. [38]Salyers MP. Tsemberis S. ACT and recovery integrating evidence based practice and recovery orientation on assertive community treatment teams Community Ment Health J. 2007 43 619 641 17514503
  36. [39]Malm U. Ivarsson B. Allebeck P. Falloon I. Integrated care in schizophrenia: a two-year randomized controlled study of two community-based treatment programs. Acta Psychiatrica Scandinavica. 2003 107 415 423 12752017
  37. [41]Van Os J. Altamura AC. Bobes J. et al. Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial. Br J Psychiatry. 2004 184 79 83 14702232
  38. [42]Hamann J. Langer B. Winkler V. et al. Shared decision making for inpatients with schizophrenia. Acta Psychiatrica Scandinavica. 2006 114 265 273 16968364
  39. [43]Priebe S. McCabe R. Bullenkamp J. Hansson L. Lauber C. Martinez-Leall R. Structured patient-clinician communication and 1-year outcome in community mental healthcare. Br J Psychiatry. 2007 191 420 426 17978322
  40. [45]Joosten EAG. de Jong CAJ. de Weert-van Oene GH TS. van der Staak CPF. Shared decision-making reduces drug use and psychiatric severity in substance-dependent patients. Psychother Psychosoin. 2009 78 245 253 19468259
  41. [46]Woltmann EM. Development and investigation of a decision support system to facilitate shared decision making in community mental health [Dissertation]. Dartmouth Medical School; Psychother Psychosoin. 2009
  42. [47]Fraenkel L. McGraw S. What are the essential elements to enable patient participation in medical decision making? J Gen Intern Med. 2007 22 614 619 17443368 PMC1855272
  43. [48]O'Connor AM. Stacey D. Entwistle V. et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003 CD001431 12804407
  44. [49]Batalden PB. Nelson EC. Mohr JJ. et al. Microsystems in health care: Part 5. How leaders are leading. JtCornrn J Qual Saf. 2003 29 297 308 14564748
  45. [50]Torrey WC. Green RL. Drake RE. Psychiatrists and psychiatric rehabilitation. J Psychiatr Pract 2005 11 155 160 15920389
  46. [52]Batalden PB. Stoltz PK. A framework for the continual improvement of health care: building and applying professional and improvement knowledge to test changes in daily work. It CommJ Quallmprov. 1993 19 424 447 discussion 48 52 8252125
  47. [53]Deegan P. Rapp CA. Holter M. Riefer M. A program to support shared decision making in an outpatient psychiatric medication clinic. Psychiatr Serv. 2008 59 603 605 18511580
  48. [54]Drake RE. Teague GB. Gersing K. State mental health authorities and informatics. Community Ment Health J. 2005 41 365 370 16131013
  49. [55]Deegan PE. Rapp C. Holter M. Riefer M. Best practices: a program to support shared decision making in an outpatient psychiatric medication clinic. Psychiatr Serv. 2008 59 603 305 18511580
  50. [56]Rimondini M. Del Piccolo L. Goss C. Mazzi M. Paccaloni M. Zimmermann C. Communication skills in psychiatry residents - how do they handle patient concerns? An application of sequence analysis to interviews with simulated patients. Psychother Psychosom. 2006 75 161 169 16636631
  51. [57]Chinman M. Young AS. Schell T. Hassell J. Mintz J. Computer-assisted self-assessment in persons with severe mental illness. J Clin Psychiatry. 2004 65 1343 1351 15491237
  52. [58]Wolford GL. Rosenberg SD. Rosenberg HJ. et al. A clinical trial comparing interviewer and computer-assisted assessment among clients with severe mental illness. Psychiatr Serv. 2008 59 769 775 18586994
  53. [59]Miller AL. Crismon ML. Rush AJ. et al. The Texas medication algorithm project: clinical results for schizophrenia. Schizophr Bull. 2004 30 627 647 15631256
  54. [60]Trivedi MH. Rush AJ. Crismon ML. et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004 61 669 680 15237079
  55. [62]Zisook S. Ganadjian K. Moutier C. Prather R. Rao S. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned. J Clin Psychiatry. 2008 69 1184 1185 18687018
  56. [63]Lieberman JA. Stroup TS. McEvoy JP. et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005 353 1209 1223 16172203
  57. [64]Laje G. Paddock S. Manji H. et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry. 2007 164 1530 1538 17898344
  58. [65]de Leon J. Pharmacogenomics: the promise of personalized medicine for CNS disorders. Neuropsychopharmacology: 2009 34 159 172 18800072
  59. [66]de Leon J. AmpliChip CYP450 test: personalized medicine has arrived in psychiatry. Expert Rev Mol Diagn. 2006 6 277 286 16706732
  60. [67]Laje G. McMahon FJ. The pharmacogenetics of major depression: past, present, and future. Biol Psychiatry. 2007 62 1205 1207 17949692
  61. [68]Lekman M. Paddock S. McMahon FJ. Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Mol Diagn Ther. 2008 12 321 330 18803430 PMC2839187
  62. [69]Lin KM. Perlis RH. Wan YJ. Pharmacogenomic strategy for individualizing antidepressant therapy. Dialogues Clin Neurosci. 2008 10 401 408 19170397 PMC3181891
  63. [70]Roberts JS. Cupples LA. Relkin NR. Whitehouse PJ. Green RC. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psychiatry Neurol. 2005 18 250 255 16306249
  64. [71]Phelan JC. Yang LH. Cruz-Rojas R. Effects of attributing serious mental illnesses to genetic causes on orientations to treatment. Psychiatr Serv. 2006 57 382 387 16524997
  65. [72]Ruano G. Quo vadis personalized medicine? Personalized Medicine. 2004 1 1 7 29793223
  66. [73]Hoop JG. Roberts LW. Green Hammond KA. Cox NJ. Psychiatrists' attitudes regarding genetic testing and patient safeguards: a preliminary study. Genet Test 2008 12 245 252 18452395
  67. [74]Dinwiddie SH. Hoop J. Gershon ES. Ethical issues in the use of genetic information. Int Rev Psychiatry. 2004 16 320 328 16200687
  68. [75]Hoop JG. Ethical considerations in psychiatric genetics. Harv Rev Psychiatry. 2008 16 322 338 19085387
  69. [76]Smets E. van Zwieten M. Michie S. Comparing genetic counseling with non-genetic health care interactions: two of a kind? Patient Educ Couns. 2007 68 225 234 17604936
  70. [77]Edwards A. Gray J. Clarke A. et al. Interventions to improve risk communication in clinical genetics: systematic review. Patient Educ Couns. 2008 71 4 25 18207694
  71. [78]Michie S. Allanson A. Armstrong D. Weinman J. Bobrow M. Marteau TM. Objectives of genetic counselling: differing views of purchasers, providers and users. J Public Health Med. 1998 20 404 408 9923946
  72. [79]Huiart L. Eisinger F. Stoppa-Lyonnet D. et al. Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultation. J Clin Epidemiol. 2002 55 665 675 12160914
  73. [80]Prathikanti S. Weinberger DR. Psychiatric genetics-the new era: genetic research and some clinical implications. Br Med Bull. 2005 73-74 107 122 16365481
  74. [82]Schwartz LM. Woloshin S. Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann intern Med. 2009 150 516 527 19221371
  75. [83]Gigerenzer G. Gaissmaier W. Kurz-Milcke E. Schwartz L. Woloshin S. Helping doctors and patients make sense of health statistics. Psychological Science in the Public interest. 2007 8 53 96 26161749
  76. [84]Hanoch Y. Pachur T. Nurses as information providers: facilitating understanding and communication of statistical information. Wurse Educ Today. 2004 24 236 243 15046859
  77. [85]Lewis C. Mehta P. Kent A. Skirton H. Coviello D. An assessment of written patient information provided at the genetic clinic and relating to genetic testing in seven European countries. Eur J Hum Genet. 2007 15 1012 1022 17568389
  78. [86]Green MJ. Peterson SK. Baker MW. et al. Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genet Med. 2005 7 22 229 PMC1201432 15834239
  79. [87]Austin JC. Honer WG. The potential impact of genetic counseling for mental illness. Clin Genet. 2005 67 134 142 15679823
  80. [88]Kessler S. Psychological aspects of genetic counseling. XIV. Nondirectiveness and counseling skills. Genet Test. 2001 5 187 191 11788083
  81. [89]Green MJ. Mclnerney AM. Biesecker BB. Fost N. Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor. Am J Med Genet. 2001 103 24 31 11562930
  82. [90]Austin JC. Honer WG. The genom ic era and serious mental illness: a potential application for psychiatric genetic counseling. Psychiatr Serv. 2007 58 254 261 17287384
  83. [91]Goss C. Moretti F. Mazzi MA. Del Piccolo L. Rimondini M. Zimmermann C. Involving patients in decisions during psychiatric consultations. Br J Psychiatry. 2008 193 416 421 18978325
  84. [92]Emery J. Is informed choice in genetic testing a different breed of informed decision-making? A discussion paper. Health Expect. 2001 4 81 86 11359537 PMC5060052
  85. [93]Bernhardt BA. Geller G. Strauss M. et al. Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women's attitudes. J Genet Couns. 1997 6 207 222 11656642
  86. [94]Gravel K. Legare F. Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions. Implementation Science. 2006 1 2 33 16899124 PMC1586024
  87. [95]Chapman GB. Niedermayer LY. What counts as a decision? Predictors of perceived decision making. Psychon Bull Rev. 2001 8 615 621 11700914
  88. [96]Chapman GB. Weber BJ. Decision biases in intertemporal choice and choice under uncertainty: testing a common account. Mem Cognit. 2006 34 589 602 16933768

Cited by

Sorted by citations

Authors
Drake, R. E., Cimpean, D., & Torrey, W. C.
Venue
Dialogues in Clinical Neuroscience
Publisher
Informa UK Limited
Published
2009-12-31
Volume
11
Issue
4
Pages
455-463
ISSN
1958-5969
DOI
10.31887/dcns.2009.11.4/redrake
PMC
PMC3181931
Cited by
139
References
5
Language
en
Licence
creativecommons.org/licenses/by-nc-nd/3.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review